Scioderm
Company

Last deal

$20M

Amount

Series B

Stage

18.12.2014

Date

3

all rounds

$37M

Total amount

General

About Company
Scioderm is a clinical stage pharmaceutical company that develops topical products for chronic skin diseases.

Industry

Sector :

Subsector :

founded date

01.01.2012

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

As a privately held, clinical-stage pharmaceutical company, Scioderm specializes in the development of dermatology therapeutics to treat chronic skin diseases. Their focus lies in creating topical products that address critical medical needs in the field. By developing drugs specifically designed for the treatment of chronic skin diseases, Scioderm aims to provide effective solutions for patients suffering from these conditions.
Contacts

Phone number

Social url